Methyl 2,3,4-Tri-O-isobutyryl Canagliflozin 2-Glucuronide is an intermediate used in the synthesis of Canagliflozin 2-Glucuronide (C175215), which is a derivative of Canagliflozin (C175190). Canagliflozin is a sodium-glucose cotransporter 2 inhibitor that is used to treat patients with type 2 diabetes. Canagliflozin lowers blood glucose by increasing the amount of glucose that exits the body through urinary excretion.